Radiation-induced heart disease: An under-recognized entity?

Current Treatment Options in Cardiovascular Medicine

Volumn 16, Issue 6, 2014, Pages

  Davis, Margot ^a   Witteles, Ronald M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cardiovascular disease; Coronary artery disease; Hodgkin lymphoma; Pericardial disease; Radiation therapy; Radiation induced heart disease; Restrictive cardiomyopathy; Valve disease

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; THALIDOMIDE;

ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVOR; COMORBIDITY; DYSLIPIDEMIA; FOLLOW UP; HEART DISEASE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; INCIDENCE; OUTCOME ASSESSMENT; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PERICARDIECTOMY; PERICARDITIS; RADIATION INJURY; REVASCULARIZATION; SCREENING; SMOKING; SURGICAL RISK;

EID: 84901285869     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-014-0317-2     Document Type: Article

References (95)

1. Seemann I et al. Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature. Radiother Oncol. 2012;103:143-50.
2. Gabriels K et al. Local heart irradiation of ApoE(-/-) mice induces microvascular and endocardial damage and accelerates coronary atherosclerosis. Radiother Oncol. 2012;105:358-64.
3. Halle M, Hall P, Tornvall P. Cardiovascular disease associated with radiotherapy: activation of nuclear factor kappa-B. J Intern Med. 2011;269:469-77.
4. Cheng RK et al. Radiation coronary arteritis refractory to surgical and percutaneous revascularization culminating in orthotopic heart transplantation. Cardiovasc Pathol. 2013;22:303-8.
5. Taylor CW et al. Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys. 2008;72:501-7.
6. Nilsson G et al. Distribution of coronary artery stenosis after radiation for breast cancer. J Clin Oncol. 2012;30:380-6.
7. Correa CR et al. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol. 2007;25:3031-7. (Pubitemid 47218049)
8. Lind PA et al. Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. Int J Radiat Oncol Biol Phys. 2003;55:914-20. (Pubitemid 36286993)
9. .• Bouillon K et al. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol. 2011;57:445-52. One of the major studies establishing the increase in long-term mortality associated with RT for BC. This study was unique in its long duration of follow-up and focus on the contribution of RT to the internal mammary lymph nodes.
10. Rademaker J et al. Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. AJR Am J Roentgenol. 2008;191:32-7. (Pubitemid 351955179)
11. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290:2831-7. (Pubitemid 37509491)
12. McEniery PT, Dorosti K, Schiavone WA, Pedrick TJ, Sheldon WC. Clinical and angiographic features of coronary artery disease after chest irradiation. Am J Cardiol. 1987;60:1020-4. (Pubitemid 17164587)
13. Hoca A, Yildiz M, Ozyigit G. Evaluation of the effects of mediastinal radiation therapy on autonomic nervous system. Med Oncol. 2012;29:3581-6.
14. Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol. 1996;27:766-73. (Pubitemid 26287216)
15. Veeragandham RS, Goldin MD. Surgical management of radiation-induced heart disease. Ann Thorac Surg. 1998;65:1014-9.
16. Cohn KE, Stewart JR, Fajardo LF, Hancock EW. Heart disease following radiation. Medicine (Baltimore). 1967;46:281-98.
17. Carver JR et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25:3991-4008. (Pubitemid 47477279)
18. Chello M et al. Changes in the proportion of types I and III collagen in the left ventricular wall of patients with post-irradiative pericarditis. Cardiovasc Surg. 1996;4:222-6. (Pubitemid 26151972)
19. Heidenreich PA, Hancock SL, Vagelos RH, Lee BK, Schnittger I. Diastolic dysfunction after mediastinal irradiation. Am Heart J. 2005;150:977-82. (Pubitemid 41607777)
20. Burns RJ et al. Detection of radiation cardiomyopathy by gated radionuclide angiography. AJM. 1983;74:297-302. (Pubitemid 13192187)
21. Constine LS, Schwartz RG, Savage DE, King V, Muhs A. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1997;39:897-906. (Pubitemid 27486078)
22. Wethal T et al. Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study. Br J Cancer. 2009;101:575-81.
23. Carlson RG, Mayfield WR, Normann S, Alexander JA. Radiation-associated valvular disease. Chest. 1991;99:538-45.
24. Crestanello JA et al. Mitral and tricuspid valve repair in patients with previous mediastinal radiation therapy. Ann Thorac Surg. 2004;78:826-31. discussion 826-31.
25. Horimoto M, Igarashi K, Takenaka T, Batra S. Pulmonary infundibular stenosis, coronary artery disease, and aortic regurgitation caused by mediastinal radiation. Am Heart J. 1993;126:1002-5. (Pubitemid 23291390)
26. Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys. 1992;22:887-96.
27. Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin' s disease. Cancer. 1992;69:1241-7.
28. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin' s disease. JAMA. 1993;270:1949-55. (Pubitemid 23312611)
29. .• Darby SC et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987-98. This recent landmark article used a case-control design and estimated cardiac RT doses to demonstrate linear relationship between the risk of CV events and cardiac RT dose in patients treated for BC. It also demonstrated that there was no lower dose threshold for increased risk, thus challenging many widely held beliefs about RIHD.
30. Clarke M et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087-106. (Pubitemid 41797643)
31. Henson KE, McGale P, Taylor C, Darby SC. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2013;108:179-82.
32. Eriksson F et al. Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model. Radiother Oncol. 2000;55:153-62. (Pubitemid 30229990)
33. Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003;42:743-9. (Pubitemid 37000197)
34. Termuhlen AM et al. Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2011;57:1210-6.
35. Mulrooney DA et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606.
36. Chung E et al. Is there a dose-response relationship for heart disease with low-dose radiation therapy? Int J Radiat Oncol Biol Phys. 2013;85:959-64.
37. Vallis KA et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol. 2002;20:1036-42. (Pubitemid 34141848)
38. Nixon AJ et al. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol. 1998;16:1374-9. (Pubitemid 28175754)
39. Kuhnt T et al. Possibility of radiotherapy-associated cardiovascular side effects in breast cancer patients by modern radiotherapy techniques. Breast J. 2007;13:103-5. (Pubitemid 46046509)
40. Petersen C, Würschmidt F. Late Toxicity of Radiotherapy: A Problem or a Challenge for the Radiation Oncologist? Breast Care (Basel). 2011;6:369-74.
41. Carmel RJ. Kaplan, H.S. Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications. Cancer. 1976;37:2813-25.
42. Højris I, Overgaard M, Christensen JJ, Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet. 1999;354:1425-30. (Pubitemid 29494754)
43. Wang W, O'Connell D, Stuart K, Boyages J. Analysis of 10-year cause-specific mortality of patients with breast cancer treated in New South Wales in 1995. J Med Imaging Radiat Oncol. 2011;55:516-25.
44. Heidenreich PA et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol. 2007;25:43-9. (Pubitemid 350003049)
45. .• Lancellotti P et al. Expert consensus for multimodality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European association of cardiovascular imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2013;26:1013-32. An excellent summary of the use of various imaging modalities in monitoring and screening for RIHD.
46. Curigliano G et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23 Suppl 7:vii155-66.
47. Erven K et al. Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy. Int J Radiat Oncol Biol Phys. 2013;85:1172-8.
48. D'Errico MP et al. N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2012;82:e239-46.
49. Jaworski C, Mariani JA, Wheeler G, Kaye DM. Cardiac complications of thoracic irradiation. J Am Coll Cardiol. 2013;61:2319-28.
50. Erven K et al. Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients. Int J Radiat Oncol Biol Phys. 2011;79:1444-51.
51. Dogan SM et al. The effect of radiotherapy on cardiac function. Coron Artery Dis. 2012;23:146-54.
52. Küpeli S et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. J Clin Oncol. 2010;28:1025-30.
53. Machann W et al. Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin' s disease. Int J Radiat Oncol Biol Phys. 2011;79:1117-23.
54. Hess SL et al. Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects. Acta Oncol. 2011;50:653-9.
55. Armstrong GT et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013. doi:10.1200/JCO.2013.49.3205.
56. Hoving S, Seemann I, VisserNL, te Poele JA, Stewart FA. Thalidomide is not able to inhibit radiation-induced heart disease. Int J Radiat Biol. 2013;89:685-91.
57. Sridharan V et al. Effects of late administration of pentoxifylline and tocotrienols in an image-guided rat model of localized heart irradiation. PLoS ONE. 2013;8:e68762.
58. Swanson T et al. Six-year experience routinely using moderate deep inspiration breath-hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early-stage or locally advanced breast cancer. Am J Clin Oncol. 2013;36:24-30.
59. Hayden AJ, Rains M, Tiver K. Deep inspiration breath hold technique reduces heart dose from radiotherapy for left-sided breast cancer. J Med Imaging Radiat Oncol. 2012;56:464-72.
60. Reardon KA et al. A comparative analysis of 3D conformal deep inspiratory-breath hold and free-breathing intensity-modulated radiation therapy for left-sided breast cancer. Med Dosim. 2013;38:190-5.
61. Formenti SC, DeWyngaert JK, Jozsef G, Goldberg JD. Prone vs supine positioning for breast cancer radiotherapy. JAMA. 2012;308:861-3.
62. Maraldo MV et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann Oncol. 2013;24:2113-8.
63. Kole TP, Aghayere O, Kwah J, Yorke ED, Goodman KA. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer. Int J Radiat Oncol Biol Phys. 2012;83:1580-6.
64. De Sanctis V et al. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy? Radiat Oncol. 2012;7:129.
65. Hoppe BS et al. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2012;84:449-55.
66. Witteles RM. Radiation therapy for breast cancer: buyer beware. J Am Coll Cardiol. 2011;57:453-4.
67. Goody RB et al. Unintended cardiac irradiation during left-sided breast cancer radiotherapy. Br J Radiol. 2013;86:20120434.
68. Tan W et al. Anterior myocardial territory may replace the heart as organ at risk in intensity-modulated radiotherapy for left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2012;82:1689-97.
69. de Almeida CE et al. Potential benefits of using cardiac gated images to reduce the dose to the left anterior descending coronary during radiotherapy of left breast and internal mammary nodes. Cancer Radiother. 2012;16:44-51.
70. Vennarini S et al. Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning. Br J Radiol. 2013;86:20120643.
71. Tjessem KH et al. Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer. Int J Radiat Oncol Biol Phys. 2013;87:337-43.
72. Whelan TJ et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513-20.
73. Stokes EL, Tyldesley S, Woods R, Wai E, Olivotto IA. Effect of nodal irradiation and fraction size on cardiac and cerebrovascular mortality in women with breast cancer treated with local and locoregional radiotherapy. Int J Radiat Oncol Biol Phys. 2011;80:403-9.
74. Appelt AL, Vogelius IR, Bentzen SM. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart. Clin Oncol (R Coll Radiol).2013;25(147-152).
75. Epstein AE et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.Circulation. 2013;127:e283-352.
76. Renner SM, Massel D, Moon BC. Mediastinal irradiation: A risk factor for atherosclerosis of the internal thoracic arteries. Can J Cardiol. 1999;15:597-600. (Pubitemid 29265493)
77. Chang AS et al. Cardiac surgery after mediastinal radiation: extent of exposure influences outcome. J Thorac Cardiovasc Surg. 2007;133:404-13.
78. Handa N et al. Coronary artery bypass grafting in patients with previous mediastinal radiation therapy. J Thorac Cardiovasc Surg. 1999;117:1136-42.
79. Park CB et al. Identifying patients at particular risk of injury during repeat sternotomy: analysis of 2555 cardiac reoperations. J Thorac Cardiovasc Surg. 2010;140:1028-35.
80. van Son JA, Noyez L, van Asten WN. Use of internal mammary artery in myocardial revascularization after mediastinal irradiation. J Thorac Cardiovasc Surg. 1992;104:1539-44. (Pubitemid 23001506)
81. Schulman HE, Korr KS, Myers TJ. Left internal thoracic artery graft occlusion following mediastinal radiation therapy. Chest. 1994;105:1881-2. (Pubitemid 24180692)
82. Khan MH, Ettinger SM. Post mediastinal radiation coronary artery disease and its effects on arterial conduits. Catheter Cardiovasc Interv. 2001;52:242-8. (Pubitemid 32115145)
83. Siregar S, de Heer F, van Herwerden LA. Cardiac surgery in patients irradiated for Hodgkin's lymphoma. Neth Heart J. 2010;18:61-5.
84. Brown ML, Schaff HV, Sundt TM. Conduit choice for coronary artery bypass grafting after mediastinal radiation. J Thorac Cardiovasc Surg. 2008;136:1167-71.
85. .• Wu W et al. Long-term survival of patients with radiation heart disease undergoing cardiac surgery: a cohort study. Circulation. 2013;127:1476-85. This is one of the largest studies of outcomes after cardiac surgery in patients with RIHD, providing important evidence of the increased risk associated with surgical procedures in this population.
86. Schömig K et al. Thoracic radiotherapy in patients with lymphoma and restenosis after coronary stent placement. Catheter Cardiovasc Interv. 2007;70:359-65. (Pubitemid 350194982)
87. Dubois CL et al. Clinical outcome of coronary stenting after thoracic radiotherapy: a case-control study. Heart. 2010;96:678-82.
88. Leon MB et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-607.
89. Smith CR et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-98.
90. Latib A et al. Percutaneous valve replacement in a young adult for radiation-induced aortic stenosis. J Cardiovasc Med (Hagerstown). 2012;13:397-8.
91. Handa N et al. Valvular heart operation in patients with previous mediastinal radiation therapy. Ann Thorac Surg. 2001;71:1880-4. (Pubitemid 32554417)
92. Ling LH et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999;100:1380-6. (Pubitemid 29451696)
93. Handa N et al. Heart transplantation for radiation-associated end-stage heart failure. Transpl Int. 2000;13:162-5. (Pubitemid 30417373)
94. DePasquale EC, Nasir K, Jacoby DL. Outcomes of adults with restrictive cardiomyopathy after heart transplantation. J Heart Lung Transplant. 2012;31:1269-75.
95. Nohria A. Should we avoid heart transplantation in cardiomyopathy due to radiotherapy/chemotherapy or amyloidosis? The devil is in the details. J Heart Lung Transplant. 2012;31:1253-6.